Journal of Clinical Pathways December 18, 2018
Health care treatments are becoming increasingly tailored to individual patients in terms of patient preferences and individual clinical factors. However, these tailored treatments often have a high price tag. Frameworks or algorithms that are able to assess the value of a specific therapy for a specific patient are needed in order to preserve access to these therapies and better integrate them into the health system from a reimbursement standpoint. Effective value frameworks must incorporate patient preferences, clinical trial subgroup assessments, and post-trial analyses into their design.
The advent of personalized medicine means that therapies are being increasingly tailored to the clinical characteristics and preferences of patients. Obviously, this is a world we all want, where the drugs match who...